» Articles » PMID: 34101297

HybraPD Atlas: Towards Precise Subcortical Nuclei Segmentation Using Multimodality Medical Images in Patients with Parkinson Disease

Overview
Journal Hum Brain Mapp
Publisher Wiley
Specialty Neurology
Date 2021 Jun 8
PMID 34101297
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human brain atlases are essential for research and surgical treatment of Parkinson's disease (PD). For example, deep brain stimulation for PD often requires human brain atlases for brain structure identification. However, few atlases can provide disease-specific subcortical structures for PD, and most of them are based on T1w and T2w images. In this work, we construct a HybraPD atlas using fused quantitative susceptibility mapping (QSM) and T1w images from 87 patients with PD. The constructed HybraPD atlas provides a series of templates, that is, T1w, GRE magnitude, QSM, R2*, and brain tissue probabilistic maps. Then, we manually delineate a parcellation map with 12 bilateral subcortical nuclei, which are highly related to PD pathology, such as sub-regions in globus pallidus and substantia nigra. Furthermore, we build a whole-brain parcellation map by combining existing cortical parcellation and white-matter segmentation with the proposed subcortical nuclei map. Considering the multimodality of the HybraPD atlas, the segmentation accuracy of each nucleus is evaluated using T1w and QSM templates, respectively. The results show that the HybraPD atlas provides more accurate segmentation than existing atlases. Moreover, we analyze the metabolic difference in subcortical nuclei between PD patients and healthy control subjects by applying the HybraPD atlas to calculate uptake values of contrast agents on positron emission tomography (PET) images. The atlas-based analysis generates accurate disease-related brain nuclei segmentation on PET images. The newly developed HybraPD atlas could serve as an efficient template to study brain pathological alterations in subcortical regions for PD research.

Citing Articles

A rapid multi-parametric quantitative MR imaging method to assess Parkinson's disease: a feasibility study.

Duan M, Pan R, Gao Q, Wu X, Lin H, Yuan J BMC Med Imaging. 2024; 24(1):58.

PMID: 38443786 PMC: 10916029. DOI: 10.1186/s12880-024-01229-0.


Prior-guided individualized thalamic parcellation based on local diffusion characteristics.

Gao C, Wu X, Wang Y, Li G, Ma L, Wang C Hum Brain Mapp. 2024; 45(4):e26646.

PMID: 38433705 PMC: 10910286. DOI: 10.1002/hbm.26646.


Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI.

Yao J, Morrison M, Jakary A, Avadiappan S, Rowley P, Glueck J J Magn Reson Imaging. 2024; 60(4):1484-1499.

PMID: 38206986 PMC: 11521114. DOI: 10.1002/jmri.29195.


Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson's disease.

Lakhani D, Zhou X, Tao S, Patel V, Wen S, Okromelidze L NPJ Parkinsons Dis. 2024; 10(1):13.

PMID: 38191546 PMC: 10774294. DOI: 10.1038/s41531-024-00631-3.


Direct localization and delineation of human pedunculopontine nucleus based on a self-supervised magnetic resonance image super-resolution method.

Li J, Guan X, Wu Q, He C, Zhang W, Lin X Hum Brain Mapp. 2023; 44(9):3781-3794.

PMID: 37186095 PMC: 10203800. DOI: 10.1002/hbm.26311.


References
1.
Deistung A, Schafer A, Schweser F, Biedermann U, Turner R, Reichenbach J . Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. 2012; 65:299-314. DOI: 10.1016/j.neuroimage.2012.09.055. View

2.
Taha A, Hanbury A . Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool. BMC Med Imaging. 2015; 15:29. PMC: 4533825. DOI: 10.1186/s12880-015-0068-x. View

3.
Oliveira Barbosa J, Santos A, Tumas V, Liu M, Zheng W, Haacke E . Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. 2015; 33(5):559-65. DOI: 10.1016/j.mri.2015.02.021. View

4.
Sun H, Walsh A, Lebel R, Blevins G, Catz I, Lu J . Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. Neuroimage. 2014; 105:486-92. DOI: 10.1016/j.neuroimage.2014.11.010. View

5.
Hanspach J, Dwyer M, Bergsland N, Feng X, Hagemeier J, Bertolino N . Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA). J Magn Reson Imaging. 2017; 46(5):1474-1484. PMC: 5587351. DOI: 10.1002/jmri.25671. View